Question· QUESTION_WRITTENE-9-2024-001297answered
Bird flu
European Union · European Parliament · 25 April 2024
Person
Joanna KOPCIŃSKA
European Union · Official source
Records
100 records where Joanna KOPCIŃSKA is listed as a sponsor, author, or other actor. Search with topics and years
Question· QUESTION_WRITTENE-9-2024-000993answered
Strategy for the development of biotechnology and bioproduction in the context of public health challenges in the EU
European Union · European Parliament · 3 April 2024
Question· QUESTION_WRITTENE-9-2024-000167answered
Methodological criterion for assessing the European Plan to Fight Cancer
European Union · European Parliament · 21 January 2024
Question· QUESTION_WRITTENE-9-2023-003764answered
List and mechanism for transposition of the category of critical medicines
European Union · European Parliament · 26 December 2023
Question· QUESTION_WRITTENE-9-2023-002996answered
Respiratory diseases in the autumn and winter season
European Union · European Parliament · 11 October 2023
Question· QUESTION_WRITTENE-9-2023-002995answered
Sepsis
European Union · European Parliament · 11 October 2023
Bill· COD2023/0132(COD)voted
Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC
European Union · European Parliament · 14 September 2023
Question· QUESTION_WRITTENE-9-2023-002450answered
Shortages of pediatric drugs in the winter period of 2023/2024
European Union · European Parliament · 28 August 2023
Question· QUESTION_WRITTENE-9-2023-001995answered
Recurrence of drug-resistant tuberculosis cases
European Union · European Parliament · 21 June 2023
Question· QUESTION_WRITTENE-9-2023-000279answered
European Cancer Imaging Initiative and GDPR
European Union · European Parliament · 31 January 2023
Question· QUESTION_WRITTENE-9-2023-000249answered
The role of MSSG EMA and HMA in the context of drug shortages
European Union · European Parliament · 26 January 2023
Bill· COD2022/0417(COD)adopted
Fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) 658/2014 of the European Parliament and of the Council
European Union · European Parliament · 15 December 2022
Question· QUESTION_ORALO-9-2022-000049open
Rebuilding European production capacity for active pharmaceutical ingredients
European Union · European Parliament · 16 November 2022
Question· QUESTION_WRITTENE-9-2022-003334answered
Assumptions of the third EU4Health work program
European Union · European Parliament · 11 October 2022
Bill· COD2022/0298(COD)adopted
Proposal for a Directive of the European Parliament and of the Council amending Directive 2009/148/EC on the protection of workers from the risks related to exposure to asbestos at work
European Union · European Parliament · 6 October 2022
Question· QUESTION_WRITTENE-9-2022-003242answered
Recommendations regarding antibiotic therapy in specific bacterial infections
European Union · European Parliament · 29 September 2022
Question· QUESTION_WRITTENE-9-2022-003241answered
Cancer Council recommendations and budget
European Union · European Parliament · 29 September 2022
Question· QUESTION_WRITTENE-9-2022-003078answered
WHO statistics and chronic COVID-19
European Union · European Parliament · 14 September 2022
Question· QUESTION_WRITTENE-9-2022-003077answered
Financial Intermediation Fund
European Union · European Parliament · 14 September 2022
Question· QUESTION_WRITTENE-9-2022-003076answered
Report on the use of drugs for COVID-19
European Union · European Parliament · 14 September 2022
Bill· COD2022/0216(COD)voted
Standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC
European Union · European Parliament · 12 September 2022
Question· QUESTION_WRITTENE-9-2022-002989answered
Titanium dioxide in food production
European Union · European Parliament · 7 September 2022
Question· QUESTION_WRITTENE-9-2022-002720answered
Acute hepatitis of unknown etiology
European Union · European Parliament · 22 July 2022
Record· QUESTION_WRITTEN_PRIORITYP-9-2022-002494open
Provenance of strains of the updated Covid-19 vaccine
European Union · European Parliament · 8 July 2022
Question· QUESTION_WRITTENE-9-2022-002495answered
Increasing trends in COVID-19 infections
European Union · European Parliament · 8 July 2022
Question· QUESTION_WRITTENE-9-2022-002100answered
PTZZ transatlantic arrangements
European Union · European Parliament · 11 June 2022
Bill· COD2022/0140(COD)voted
European Health Data Space
European Union · European Parliament · 6 June 2022
Question· QUESTION_WRITTENE-9-2022-001991answered
Monkeypox
European Union · European Parliament · 31 May 2022
Question· QUESTION_WRITTENE-9-2022-001853answered
Change of the Commission's position on the Russian ultimatum regarding gas payments in rubles
European Union · European Parliament · 18 May 2022
Question· QUESTION_WRITTENE-9-2022-001683answered
European Health Data Space
European Union · European Parliament · 4 May 2022
Question· QUESTION_WRITTENE-9-2022-001682answered
Measles outbreak and COVID-19
European Union · European Parliament · 4 May 2022
Question· QUESTION_WRITTENE-9-2022-001680answered
Acute hepatitis
European Union · European Parliament · 4 May 2022
Question· QUESTION_WRITTENE-9-2022-001511answered
A fund to compensate health care costs and work synergies
European Union · European Parliament · 21 April 2022
Question· QUESTION_WRITTENE-9-2022-001493answered
Ukraine and public health in the Multiannual Indicative Program 2021-27
European Union · European Parliament · 20 April 2022
Question· QUESTION_WRITTENE-9-2022-001492answered
Development of a health profile of Ukraine
European Union · European Parliament · 20 April 2022
Question· QUESTION_WRITTENE-9-2022-000986answered
Criteria for recommendations on the labeling of antimicrobials
European Union · European Parliament · 14 March 2022
Question· QUESTION_WRITTENE-9-2022-000474answered
AER reporting to the EudraVigilance system during the Covid-19 pandemic
European Union · European Parliament · 3 February 2022
Question· QUESTION_WRITTENE-9-2022-000140answered
New contracts and Omicron fluctuations
European Union · European Parliament · 12 January 2022
Question· QUESTION_WRITTENE-9-2021-005636answered
Omicron 2
European Union · European Parliament · 20 December 2021
Question· QUESTION_WRITTENE-9-2021-005089answered
REGEN-COV drug
European Union · European Parliament · 11 November 2021
Question· QUESTION_WRITTENE-9-2021-005037answered
Drug use in COVID-19 and the risk of evolution of antimicrobial resistance
European Union · European Parliament · 9 November 2021
Question· QUESTION_WRITTENE-9-2021-004786answered
AY variant 4.2
European Union · European Parliament · 21 October 2021
Question· QUESTION_WRITTENE-9-2021-004673answered
Moderna and the Nordic countries
European Union · European Parliament · 14 October 2021
Question· QUESTION_WRITTENE-9-2021-004385answered
Vaccination and non-vaccination in virus transmission
European Union · European Parliament · 27 September 2021
Question· QUESTION_WRITTENE-9-2021-004159answered
Europejski format wymiany elektronicznej dokumentacji medycznej
European Union · European Parliament · 9 September 2021
Question· QUESTION_WRITTENE-9-2021-003992answered
Commission action on the use of the third dose of the coronavirus vaccine
European Union · European Parliament · 31 August 2021
Record· QUESTION_WRITTEN_PRIORITYP-9-2021-003895open
Rules on mask-wearing
European Union · European Parliament · 15 August 2021
Question· QUESTION_WRITTENE-9-2021-003896answered
Children's vaccinations
European Union · European Parliament · 15 August 2021
Question· QUESTION_WRITTENE-9-2021-003381answered
Delta variant
European Union · European Parliament · 30 June 2021
Question· QUESTION_WRITTENE-9-2021-003078answered
Antibody research
European Union · European Parliament · 10 June 2021